Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT4O5P0)

DTT Name	Helodermin-preferring VIP receptor (VIPR2) DTT Info
Gene Name	VIPR2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PB1046	DM8MJ3F	Heart failure	BD10-BD13	Phase 2	[1]
RG-7103	DM2IDQ9	Chronic obstructive pulmonary disease	CA22	Phase 1	[2]
------------------------------------------------------------------------------------

3 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
helodermin	DMIUABO	Discovery agent	N.A.	Investigative	[3]
PACAP-27	DMB26IK	Discovery agent	N.A.	Investigative	[4]
PB-1120	DMX7WU9	Discovery agent	N.A.	Investigative	[5]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of PhaseBio Pharmaceuticals.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027925)
3	Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors. Ann N Y Acad Sci. 1998 Dec 11;865:247-52.
4	A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology. Neuropharmacology. 2006 Nov;51(6):1086-98.
5	Company report (PhaseBio)